March 17, 2025 12:16 PM EDTUpdated 12:46 PM

All selected drugmakers agree to second round of price negotiations under the IRA

Nicole DeFeudis

Editor

The second round of Medicare price negotiations is now underway for all 15 selected drugs with signed agreements in place from the manufacturers of those …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

All selected drugmakers agree to second round of price negotiations under the IRA

Nicole DeFeudis

Editor

Sign up to read this article for free.

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

Trump’s HHS defends Biden-era stance on 340B rebate models

FDA staff return to White Oak campus en masse after Trump administration push

Incyte's stock sinks as pivotal skin disease data disappoint

AstraZeneca taps Alteogen in deal worth more than $1.3B to make subcutaneous cancer drugs

George Church spinout developing genomically recoded organisms cuts most employees

AstraZeneca to buy cell therapy startup for $425M upfront

All se­lect­ed drug­mak­ers agree to sec­ond round of price ne­go­ti­a­tions un­der the IRA

Editor

Sign up to read this article for free.

more like this

Gondolabio

Palo Alto, CA, USA

All selected drugmakers agree to second round of price negotiations under the IRA